The European Union has slapped a $475 million fine on U.S. biotech giant Illumina for buying out cancer-screening company Grail without the approval of the 27-nation bloc’s antitrust watchdog.
Source link
EU fines US firm Illumina $475 million for jumping gun on buyout of cancer-screening company Grail
RELATED ARTICLES